Table 3.
Comparisons of pretreatment circulating AFR, Fib, Alb, NLR, PLR in different subgroups stratified by tobacco and TNM stage
| Variables | AFR Median (95% CI) | P * | FIB (mg/dL) Median (95% CI) | P * | Alb (g/L) Median (95% CI) | P * | NLR Median (95% CI) | P * | PLR Median (95% CI) | P * |
|---|---|---|---|---|---|---|---|---|---|---|
| Tobacco | ||||||||||
| Yes | 10.33 (9.34–11.90) | 0.356 | 3.70 (3.22–4.02) | 0.512 | 38.91 (38.33–39.41) | 0.182 | 2.80 (2.63–3.08) | 0.308 | 141.94 (130.76–153.73) | 0.411 |
| No | 10.22 (9.40–13.53) | 3.76 (3.09–4.00) | 39.27 (38.90–40.28) | 2.66 (2.42–2.97) | 128.41 (114.53–150.37) | |||||
| Stage | ||||||||||
| I | 12.99 (9.76–14.56) | 0.171 | 3.20 (2.60–3.67) | 0.237 | 39.42 (38.01–40.89) | 0.045* | 2.10 (1.86–2.66) | 0.001* | 109.16 (91.83–130.77) | 0.004* |
| II | 11.88 (10.01–14.19) | 3.42 (2.81–3.79) | 39.58 (38.60–40.05) | 2.58 (2.31–2.82) | 132.04 (117.83–150.42) | |||||
| III | 9.93 (8.94–12.15) | 3.94 (3.30–D4.41) | 39.20 (38.82–40.00) | 2.78 (2.58–3.03) | 143.26 (123.81–159.10) | |||||
| IV | 9.30 (8.35–12.37) | 3.92 (3.20–4.46) | 38.50 (37.26–39.18) | 3.28 (2.81–3.69) | 152.20 (132.66–167.04) | |||||
*P < 0.05 is significant.